|
Medical News Regular Pap Smear Is as Effective as ThinPrepOctober 28, 2009 The liquid-based cytology test ThinPrep now represents 70 percent of the U.S. cervical cancer screening market, but a new report finds it no more effective than the conventional Pap smear at detecting precancerous cells. Many doctors were forced to switch to the test when labs stopped reading Pap smears, said George Sawaya, an obstetrician/gynecologist at the University of California-San Francisco. The results of the new study "should serve as a cautionary tale that just because something is new doesn't mean it's better," he said. Lead author Albertus G. Siebers, MSc, said other factors to consider include the ability to use ThinPrep samples to test for human papillomavirus -- the STD that causes nearly all cases of cervical cancer -- and the fact that only one in 300 ThinPrep tests had to be redone, versus one in 100 Pap tests. The report, "Comparison of Liquid-Based Cytology with Conventional Cytology for Detection of Cervical Cancer Precursors," and the editorial, "Screening and Prevention Methods for Cervical Cancer," were published in the Journal of the American Medical Association (2009;302(16):1757-1764,1809-1810). USA Today 10.28.2009; Rita Rubin This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
|